Trial purpose
Cancer treatment
Tumor type
Breast
Age
18 - 75
Clinical summary
Summary
Patients will be given either docetaxcel or anthracycline based chemotherapy prior to surgery. The tumour will be measured both before and after after the chemotherapy. All the measurements including radiological and laboratory from the tumour tissue are then assessed. Trial runs for 24 weeks.
Conditions
This trial is treating people with breast cancer
Eligibility
Inclusion
locally advanced breast cancer
Exclusion
metastatic disease (Stage 4)
Inclusion
- Your cancer has not spread to other parts of the body (localised).
Clinical trials have complex eligibility criteria, and other criteria may apply for this trial. Ask your doctor about whether this trial could be right for you.
More information
Trial Identifiers
Information on this page is partially produced from ANZCTR *. View further details about this trial on the registry via the links below:
Trial sponsor
Sanofi Aventis,Southern Health
Scientific Title
Neoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response: A pilot study.
Get Support
You might find it helpful to speak to someone who has 'been there before'. Our Peer Connect program can provide one-on-one phone support from someone who understands what you're going through and has clinical trials experience.
Know more about Peer Connect
If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council to speak with an experienced health professional on 13 11 20.
Get support
Learn more about clinical trials through this collection of resources in languages other than English.
View information